Persistence of hepatitis B viremia after recovery from acute hepatitis B: Correlation between anti-HBc titer and HBV DNA in serum

Hepatology Research

Volumn 24, Issue 1, 2002, Pages 8-17

  Akahane, Yoshihiro ^a   Okada, Shun Ichi ^a   Sakamoto, Minoru ^a   Wakamiya, Minoru ^a   Kitamura, Takatoshi ^a   Tawara, Akio ^a   Naitoh, Shigeko ^a   Tsuda, Fumio ^b   Okamoto, Hiroaki ^c  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b Shinagawa ku   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti HBe titer (HI test); Convalescent stage; Hepatitis B viremia; Self limited acute hepatitis B

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; PRIMER DNA; VIRUS DNA;

ACUTE HEPATITIS; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FOLLOW UP; GENE SEQUENCE; GENOTYPE; HEMAGGLUTINATION INHIBITION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; PLASMA CLEARANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEROLOGY; VIREMIA; VIRUS DETECTION;

EID: 0036737803     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(02)00015-3     Document Type: Article

References (35)

1. Krugman S, Overby LR, Mushahwar IK, Ling C-M, Frösner GG, Deinhardt F. Viral hepatitis, type B. Studies on natural history and prevention re-examined. N Engl J Med 1979;300:101-6.
2. Hoofnagle J.H. Type B hepatitis: virology, serology and clinical course. Semin Liv Dis 1981;1:7-14.
3. Yotsuyanagi H, Yasuda K, Iino S, et al. Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 1998;27:1377-82.
4. Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 1994;93:230-9.
5. Penna A, Artini M, Cavalli A, et al. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 1996;98:1185-94.
6. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996;2:1104-8.
7. Liang TJ, Isselbacher KJ, Wands JR. Rapid identification of low level hepatitis B-related viral genome in serum. J Clin Invest 1989;84:1367-71.
8. Liang TJ, Blum HE, Wands JR. Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serological markers. Hepatology 1990;12:204-12.
9. Wang JT, Wang TH, Shen JC, Shih LN, Lin JT, Chen DS. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis 1991;163:397-9.
10. Chazouillères O, Mamish D, Kim M, et al. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994;343:142-6.
11. Wachs ME, Amend WJ, Ascher NL, et al. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBcIgM(-) organ donors. Transplantation 1995;59:230-4.
12. Dickson RC, Everhart JE, Lake JR, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology 1997;113:1668-74.
13. Roche B, Samuel D, Gigou M, et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol 1997;26:517-26.
14. Uemoto S, Sugiyama K, Marusawa H, et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 1998;65:494-9.
15. Korba BE, Wells FV, Baldwin B, et al. Hepatocellular carcinoma in woodchuck hepatitis virus-infected wood-chucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections. Hepatology 1989;3:461-70.
16. Kubo S, Nishiguchi S, Hirohashi K, et al. Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma. Cancer 1999;86:793-8.
17. Morgan TR, Redeker AG, Yamada S, Ashcavai M. HBsAg clearance in chronic active hepatitis B. A possible cause of cryptogenic cirrhosis. Dig Dis Sci 1986;31:700-4.
18. Carman WF, Dourakis S, Karayiannis P, Crossey M, Drobner R, Thomas HC. Incidence of hepatitis B viremia, detected using the polymerase chain reaction, after successful therapy of hepatitis B virus carriers with interferon-α. J Med Virol 1991;34:114-8.
19. Adachi H, Kaneko S, Matsushita E, Inagaki Y, Unoura M, Kobayashi K. Clearance of HBsAg in seven patients with chronic hepatitis B. Hepatology 1992;16:1334-7.
20. Huo TI, Wu JC, Lee PC, et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998;28:231-6.
21. Fong TL, Di Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 1993;18:1313-8.
22. Kuhns M, McNamara A, Mason A, Campbell C, Perrillo R. Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen. Gastroenterology 1992;103:1649-56.
23. Mason AL, Xu L, Guo L, Kuhns M, Perrillo RP. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 1998;27:1736 42.
24. lizuka H, Ohmura K, Ishijima A, et al. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992;63:107-11.
25. Japanese Red Cross Non-A, Non-B Hepatitis Research Group. Effect of screening for hepatitis C antibody and hepatitis B core antibody on incidence of post-transfusion hepatitis. Lancet 1991;338:1040-1.
26. Okamoto H, Tsuda F, Sakugawa H, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 1988;69:2575-83.
27. Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994;198:489-503.
28. Stuyver L, De Gendt S, Van Geyt C, et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 2000;81:67-74.
29. Okamoto H, Imai M, Tsuda F, Tanaka T, Miyakawa M. Mayumi M. Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol 1987;61:3030-4.
30. Sastrosoewignjo RI, Sandjaja B, Okamoto H. Molecular epidemiology of hepatitis B virus in Indonesia. J Gastroenterol Hepatol 1991;6:491-8.
31. Kao JH, Chen PJ, Lai MY, et al. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000;118:554-9.
32. Usuda S, Okamoto H, Iwanari H, et al. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Meth 1999;80:97-112.
33. Kobayashi M, Chayama K, Arase Y, et al. Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance. J Gastroenterol 2000;35:753-7.
34. Chang MH, Hsu HY, Huamg LM, Lee PI, Lin HH, Lee CY. The role of transplacental hepatitis B core antibody in the mother-to-infant transmission of hepatitis B virus. J Hepatol 1996;24:674-9.
35. Lee JH, Paglieronic TG, Holland PV, Zeldis JB. Chronic hepatitis B virus infection in an HBc antibody-nonreactive blood donor: variant virus or defective immune response? Hepatology 1992;16:24-30.